Avacta Therapeutics
  • About
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
Home News
filter by: view all | Blogs | Diagnostics | Investors | Podcasts and Videos | R&D Spotlights Series | Therapeutics

News

09 Sep 2024

Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress

Investors | Therapeutics
02 Sep 2024

Director/PDMR Shareholdings and Total Voting Rights

Investors
12 Aug 2024

Research & Development Spotlight Series – Episode 4

Blogs | Podcasts and Videos | R&D Spotlights Series | Therapeutics
18 Jul 2024

Update on Convertible Bond Payment

Investors
08 Jul 2024

Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors

Investors
26 Jun 2024

Result of Annual General Meeting

Investors
26 Jun 2024

AGM Business Update

Investors
20 Jun 2024

Shaun Chilton is appointed Non-Executive Chairman of the Avacta Board of Directors

Investors
11 Jun 2024

Appointment of Nominated Adviser and Sole Broker

Investors
03 Jun 2024

Research & Development Spotlight Series – Episode 3

Blogs | Investors | Podcasts and Videos | R&D Spotlights Series | Therapeutics

Posts navigation

Older posts
Newer posts
Avacta Therapeutics
  • Diagnostics
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Corporate Responsibility
  • Contact Us

Avacta Group plc

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3911 0353

Investor Enquiries

ICR Consilium
85 Gresham Street
London
EC2V 7NQ

 

Email

Twitter | Linkedin

©2025 Avacta Therapeutics. Registered company no. 06605196.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok